These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 31649870)

  • 41. The Chemokine CXCL7 Is Related to Angiogenesis and Associated With Poor Prognosis in Colorectal Cancer Patients.
    Li L; Jiang K; Li D; Li D; Fan Z; Dai G; Tu S; Liu X; Wei G
    Front Oncol; 2021; 11():754221. PubMed ID: 34692540
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression level of CXCL7 in peripheral blood cells is a potential biomarker for the diagnosis of renal cell carcinoma.
    Kinouchi T; Uemura M; Wang C; Ishizuya Y; Yamamoto Y; Hayashi T; Matsuzaki K; Nakata W; Yoshida T; Jingushi K; Kawashima A; Ujike T; Nagahara A; Fujita K; Imamura R; Ueda Y; Kitae K; Tsujikawa K; Nonomura N
    Cancer Sci; 2017 Dec; 108(12):2495-2502. PubMed ID: 28985012
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Applicative Value of Serum CA19-9, CEA, CA125 and CA242 in Diagnosis and Prognosis for Patients with Pancreatic Cancer Treated by Concurrent Chemoradiotherapy.
    Gu YL; Lan C; Pei H; Yang SN; Liu YF; Xiao LL
    Asian Pac J Cancer Prev; 2015; 16(15):6569-73. PubMed ID: 26434876
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical value of a diagnostic score for colon cancer based on serum CEA, CA19-9, cytokeratin-1 and mucin-1.
    Attallah AM; El-Far M; Ibrahim AR; El-Desouky MA; Omran MM; Elbendary MS; Attallah KA; Qura ER; Abdallah SO
    Br J Biomed Sci; 2018 Jul; 75(3):122-127. PubMed ID: 29734875
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The diagnostic value of five serum tumor markers for patients with cholangiocarcinoma.
    Qiu Y; He J; Chen X; Huang P; Hu K; Yan H
    Clin Chim Acta; 2018 May; 480():186-192. PubMed ID: 29438681
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasma Exosomal CXCL7 is a Potential Biomarker for Lung Adenocarcinoma.
    Fang W; You J; Xu Q; Jiang Y; Hu H; Chen F; Chen L
    Clin Lab; 2022 Oct; 68(10):. PubMed ID: 36250818
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum SYPL1 is a promising diagnostic biomarker for colorectal cancer.
    Liu L; He Q; Li Y; Zhang B; Sun X; Shan J; Pan B; Zhang T; Zhao Z; Song X; Guo Y
    Clin Chim Acta; 2020 Oct; 509():36-42. PubMed ID: 32502495
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased lung cancer risk in patients with interstitial lung disease and elevated CEA and CA125 serum tumour markers.
    Dai H; Liu J; Liang L; Ban C; Jiang J; Liu Y; Ye Q; Wang C
    Respirology; 2014 Jul; 19(5):707-13. PubMed ID: 24903079
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical Value of Serum p53 Antibody in the Diagnosis and Prognosis of Colorectal Cancer.
    Kunizaki M; Sawai T; Takeshita H; Tominaga T; Hidaka S; To K; Miyazaki T; Hamamoto R; Nanashima A; Nagayasu T
    Anticancer Res; 2016 Aug; 36(8):4171-5. PubMed ID: 27466527
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of mannose receptor and CD163 as novel biomarkers for colorectal cancer.
    Ding D; Yao Y; Yang C; Zhang S
    Cancer Biomark; 2018 Feb; 21(3):689-700. PubMed ID: 29226859
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification and Validation of Novel Serum Autoantibody Biomarkers for Early Detection of Colorectal Cancer and Advanced Adenoma.
    Wang H; Zhang B; Li X; Zhou D; Li Y; Jia S; Qi S; Xu A; Zhao X; Wang J; Bai Z; Cao B; Li N; Dai M; Chen H; Huang J
    Front Oncol; 2020; 10():1081. PubMed ID: 32793472
    [No Abstract]   [Full Text] [Related]  

  • 52. Circulating midkine in malignant and non-malignant colorectal diseases.
    Krzystek-Korpacka M; Diakowska D; Neubauer K; Gamian A
    Cytokine; 2013 Oct; 64(1):158-64. PubMed ID: 23899719
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Improved diagnostic value by combining plasma PON1 level with tumor biomarkers in Colorectal Cancer patients.
    Zhang J; Yang X; Wei L; Tan H; Chen J; Li W; Chan K; Su Y; Zhao L; Hu S; Zhong S; Xiao Y; Liu H
    J Cancer; 2020; 11(22):6491-6496. PubMed ID: 33046970
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Investigation of MicroRNA-21 Expression Levels in Serum and Stool as a Potential Non-Invasive Biomarker for Diagnosis of Colorectal Cancer.
    Bastaminejad S; Taherikalani M; Ghanbari R; Akbari A; Shabab N; Saidijam M
    Iran Biomed J; 2017 Mar; 21(2):106-13. PubMed ID: 27432735
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasma Methylated SEPT9 as a Novel Biomarker for Predicting Liver Metastasis in Colorectal Cancer.
    Yu M; Yang C; Wang S; Shi Y; Wang J; Meng C; Xue L; Chen Z
    Mol Biotechnol; 2024 Sep; 66(9):2254-2261. PubMed ID: 37608077
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Higher plasma concentration of TP53-induced glycolysis and apoptosis regulator is associated with a lower risk of colorectal cancer metastasis.
    Lin L; Mi Y; Li X; Peng C; Shangguan Z; Li Z; Liu S
    Cancer Manag Res; 2019; 11():263-272. PubMed ID: 30636898
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predictive Value of Carcinoembryonic and Carbohydrate Antigen 19-9 Related to Some Clinical, Endoscopic and Histological Colorectal Cancer Characteristics.
    Tomašević R; Milosavljević T; Stojanović D; Gluvić Z; Dugalić P; Ilić I; Vidaković R
    J Med Biochem; 2016 Sep; 35(3):324-332. PubMed ID: 28356884
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative study of CEA and CA19-9 in esophageal, gastric and colon cancers individually and in combination (ROC curve analysis).
    Bagaria B; Sood S; Sharma R; Lalwani S
    Cancer Biol Med; 2013 Sep; 10(3):148-57. PubMed ID: 24379990
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical Significance of Serum HE4, CA125, CA724, and CA19-9 in Patients With Endometrial Cancer.
    Bian J; Sun X; Li B; Ming L
    Technol Cancer Res Treat; 2017 Aug; 16(4):435-439. PubMed ID: 27562869
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of antibody level against Fusobacterium nucleatum in the serological diagnosis of colorectal cancer.
    Wang HF; Li LF; Guo SH; Zeng QY; Ning F; Liu WL; Zhang G
    Sci Rep; 2016 Sep; 6():33440. PubMed ID: 27678333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.